DA
PMD

Denali Advisors’s Psychemedics Corporation PMD Stock Holding History

Denali Advisors’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-98
Closed -$1K – 369
2019
Q4 		$1K Hold
98
– – ﹤0.01% 312
2019
Q3 		$1K Sell
98
-84
-46% -$714 ﹤0.01% 298
2019
Q2 		$2K Buy
182
+98
+117% +$1.11K ﹤0.01% 283
2019
Q1 		$1K Hold
84
– – ﹤0.01% 254
2018
Q4 		$1K Buy
84
+44
+110% +$758 ﹤0.01% 243
2018
Q3 		$1K Sell
40
-40
-50% -$796 ﹤0.01% 247
2018
Q2 		$2K Hold
80
– – ﹤0.01% 252
2018
Q1 		$2K Hold
80
– – ﹤0.01% 246
2017
Q4 		$2K Buy
80
+20
+33% +$371 ﹤0.01% 243
2017
Q3 		$1K Buy
+60
New +$1.32K ﹤0.01% 253

Other funds holding PMD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Denali Advisors's PMD Position: Q1 2020 in Review

Denali Advisors sold out of Psychemedics Corporation (PMD) in Q1 2020, closing a stake of 98 shares — an estimated $1K sold.

Denali Advisors first reported a position in PMD in Q3 2017 and held it in 10 quarters. The position peaked at $2K in Q2 2019. 37 funds tracked by Wall St. Rank hold PMD as of Q1 2020.

  • Denali Advisors reported no remaining Psychemedics Corporation position as of Q1 2020 after selling out during the quarter.
  • Denali Advisors sold 98 Psychemedics Corporation shares in Q1 2020, an estimated $1K.
  • Denali Advisors first reported a position in Psychemedics Corporation in Q3 2017 and held it in 10 quarters.
  • Denali Advisors's Psychemedics Corporation position peaked at $2K in Q2 2019.
  • 37 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2020.

Based on Denali Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.